Sample Size Estimation for Negative Binomial Regression Comparing Rates of Recurrent Events with Unequal Follow-Up Time

References

• Andersen, P. K., Gill, R. D. (1982). Cox’s regression model for counting processes: A large sample study. Annals of Statistics 24:1100–1120.
   Web of Science ®Google Scholar
• Bernardo, M. V. P., Harrington, D. P. (2001). Sample size calculations for the two-sample problem using the multiplicative intensity model. Statistics in Medicine 20:557–579.
   PubMed Web of Science ®Google Scholar
• Committee for Medicinal Products for Human Use (CHMP) (2007). Reflection paper on methodological issues in confirmatory clinical trials planned with an adaptive design. CHMP/EWP/2459/02. URL http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003616.pdf.
   Google Scholar
• Cook, R., Bergeron, P. J., Boher, J. M., Liu, Y. (2009). Two-stage design of clinical trials involving recurrent events. Statistics in Medicine 28:2617–2638.
   PubMed Web of Science ®Google Scholar
• Cook, R. J. (1995). The design and analysis of randomized trials with recurrent events. Statistics in Medicine 14:2081–2098.
   PubMed Web of Science ®Google Scholar
• Dean, C. B., Balshaw, R. (1997). Efficiency lost by analyzing counts rather than event times in poisson and overdispersed poisson regression models. Journal of the American Statistical Association 92:1387–1398.
   Web of Science ®Google Scholar
• Food and Drug Administration (FDA) (2010). Guidancefor industry–adaptive design clinical trials for drugs and biologics. Draft guidance. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm201790.pdf.
   Google Scholar
• Friede, T., Schmidli, H. (2010a). Blinded sample size reestimation with count data: Methods and applications in multiple sclerosis. Statistics in Medicine 29:1145–1156.
   PubMed Web of Science ®Google Scholar
• Friede, T., Schmidli, H. (2010b). Blinded sample size reestimation with negative binomial counts in superiority and non-inferiority trials. Methods of Information in Medicine 49:618–624.
   PubMed Web of Science ®Google Scholar
• Inusah, S., Sormani, M. P., Cofield, S. S., Aban, I. B., Musani, S. K., Srini-vasasainagendra, V., Cutter, G. R. (2010). Assessing changes in relapse rates in multiple sclerosis. Multiple Sclerosis 16:1414–1421.
   PubMed Web of Science ®Google Scholar
• Kappos, L., Antel, J., Comi, G., Montalban, X., O’Connor, P., Polman, C. H., Haas, T., Korn, A. A., Radue, G. K. E. W. (2006). Oral fingolimod (FTY720) for relapsing multiple sclerosis. The New England Journal of Medicine 355:1124–1140.
   PubMed Web of Science ®Google Scholar
• Kappos, L., Radue, E.-W., O’Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Burtin, L. Z.-A. P. (2010). A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. The New England Journal of Medicine 362:387–401.
   PubMed Web of Science ®Google Scholar
• Keene, O. N., Jones, M. R., Lane, P. W., Anderson, J. (2007). Analysis of exacerbation rates in asthma and chronic obstructive pulmonary disease: Example from the TRISTAN study. Pharmaceutical Statistics 6:89–97.
   PubMed Web of Science ®Google Scholar
• Lawless, J. F. (1987). Negative binomial and mixed Poisson regression. The Canadian Journal of Statistics 15:209–225.
   Web of Science ®Google Scholar
• Lawless, J. F., Nadeau, C. (1995). Some simple robust methods for the analysis of recurrent events. Technometrics 37:158–168.
   Web of Science ®Google Scholar
• Lin, D. Y., Wei, L. J., Yang, I., Ying, Z. (2000). Semiparametric regression for the mean and rate functions of recurrent events. Journal of the Royal Statistical Society B 62:711–730.
   Google Scholar
• Little, R., Yau, L. (1996). Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics 52:1324–1333.
   PubMed Web of Science ®Google Scholar
• Matsui, S. (2005). Sample size calculations for comparative clinical trials with over-dispersed Poisson process data. Statistics in Medicine 24:1339–1356.
   PubMed Web of Science ®Google Scholar
• Nicholas, R., Straube, S., Schmidli, H., Schneider, S., Friede, T. (2011). Trends in annualized relapse rates in relapsing remitting multiple sclerosis and consequences for clinical trial design. Multiple Sclerosis 17:1211–1217.
   PubMed Web of Science ®Google Scholar
• Robertson, M. C., Campbell, A. J., Herbison, P. (2005). Statistical analysis of efficacy in falls prevention trials. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 60:530–534.
   PubMed Web of Science ®Google Scholar
• Schneider, S., Schmidli, H., Friede, T. (2013). Blinded sample size re-estimation for recurrent event data with time trends. Statistics in Medicine 32:5448–5457.
   PubMed Web of Science ®Google Scholar
• Song, R., Kosorok, M. R., Cai, J. (2008). Robust covariate-adjusted log-rank statistics and corresponding sample size formula for recurrent events data. Biometrics 92:741–750.
   Web of Science ®Google Scholar
• Spruance, S. L., Reid, J. E., Grace, M., Samore, M. (2004). Hazard ratio in clinical trials. Antimicrobial Agents and Chemotherapy 48:2787–2792.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Meyerson, L., Tang, Y., Qian, N. (2009). Statistical methods for the analysis of relapse data in MS clinical trials. Journal of the Neurological Sciences 285:206–211.
   PubMed Web of Science ®Google Scholar